Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.61 |
| ▸ | ACE | P12821 | 6/20 | 0.56 |
| ▸ | CPA1 | P15085 | 4/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.56 |
| ▸ | GNPAT | O15228 | 1/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
| ▸ | CTSC | P53634 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8068326 | 1.00 | MME (0.61) | MMEACECPA1ACE2GNPAT | |
| SCHEMBL4432590 | 0.94 | CTSC (0.60) | MMEACEITGB3ITGA2BCTSC | |
| SCHEMBL232698 | 0.94 | CTSC (0.60) | MMEACEITGB3ITGA2BCTSC | |
| SCHEMBL232699 | 0.94 | CTSC (0.60) | MMEACEITGB3ITGA2BCTSC | |
| SCHEMBL31607204 | 0.93 | MME (0.55) | MMEACECPA1ACE2GNPAT | |
| SCHEMBL29350849 | 0.93 | MME (0.63) | MMEACE | |
| SCHEMBL29603463 | 0.93 | MME (0.63) | MMEACE | |
| SCHEMBL13588078 | 0.93 | MME (0.63) | MMEACE | |
| SCHEMBL29602654 | 0.93 | MME (0.63) | MMEACE | |
| SCHEMBL30900762 | 0.93 | MME (0.59) | MMEACECPA1ACE2GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1916 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113480631-B | Horseshoe head bats source antibacterial peptide RF-CATH2 and application thereof | 贵州师范大学 | 2022-06-21 | — | — | CN | claimed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-114761428-B | Anti-hemagglutinin antibodies and methods of use thereof | 瑞泽恩制药公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-115925966-B | Recombinant thyroid stimulating hormone receptor protein, preparation method and application | 厦门英博迈生物科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-113881680-B | T cell antigen receptor, multimeric complex thereof, and preparation method and application thereof | 华夏英泰（北京）生物技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-112752837-B | Natural killer cells | 帝国理工学院创新有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12576136-B2 | Insulin derivative | GAN & LEE PHARMACEUTICALS CO., LTD. (CN) | 2026-03-17 | — | — | US | disclosed |
| CN-115704050-B | POGLUT3 as gastrointestinal tract disease biomarker and application thereof | 广州市妇女儿童医疗中心 | 2026-02-27 | — | — | CN | disclosed |
| US-20250376671-A1 | ARGINASE-INSULIN FUSION PROTEIN | KYON BIOTECH AG (CH) | 2025-12-11 | — | — | US | disclosed |
| US-12435116-B2 | Compounds, compositions, methods, and uses for treating insulin resistance, type 2 diabetes and metabolic syndrome | LINK THERAPEUTICS, LLC | 2025-10-07 | — | — | US | disclosed |
| CN-113957088-A | Artificial design and application of intercellular communication system | 中国科学院微生物研究所 | 2022-01-21 | — | — | CN | disclosed |
| US-6074555-A | HYDROPHOBIC SURFACES IN THE PORES AND HYDROPHILIC OUTER SURFACES. | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2000-06-13 | — | — | US | disclosed |
| US-5672422-A | Packing material for column and process for production thereof | SHISEIDO COMPANY LTD. (JP) | 1997-09-30 | — | — | US | disclosed |
| EP-0537461-B1 | Modified chromatographic support | MERCK PATENT GMBH (DE) | 1996-07-24 | — | — | EP | disclosed |
| EP-0501786-B1 | Packing material for column and process for production thereof | SHISEIDO CO LTD (JP) | 1996-04-17 | — | — | EP | disclosed |
| EP-0425104-B1 | Column packing material | SHISEIDO CO LTD (JP) | 1993-12-22 | — | — | EP | disclosed |
| EP-0537461-A1 | Modified chromatographic support | MERCK PATENT GmbH (DE) | 1993-04-21 | — | — | EP | disclosed |
| EP-0501786-A1 | Packing material for column and process for production thereof | SHISEIDO COMPANY LIMITED (JP) | 1992-09-02 | — | — | EP | disclosed |
| US-5135649-A | Silicone polymer having bonded hydrocarbon and polyoxyalkylene or hydroxyl groups | SHISEIDO COMPANY LTD. (JP) | 1992-08-04 | — | — | US | disclosed |
| EP-0425104-A1 | Column packing material | SHISEIDO COMPANY LIMITED (JP) | 1991-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576136-B2 | Insulin derivative | GLP1R, IAPP, INSR | MME 2454/4885ACE 3006/4885CPA1 2486/4885 |
| US-12435116-B2 | Compounds, compositions, methods, and uses for treating insulin resistance, type 2 diabetes and metabolic syndrome | INSR, IRS1, INSRR | MME 1275/4885ACE 1727/4885CPA1 1251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.